Chembio Diagnostics Inc.

-0.06 (-1.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)115.41M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.77 Million
Adjusted EPS-$0.28
See more estimates
10-Day MA$6.21
50-Day MA$6.06
200-Day MA$5.77
See more pivots

Chembio Diagnostics, Inc. Stock, NASDAQ:CEMI

555 Wireless Boulevard, Hauppauge, New York 11788
United States of America
Phone: +1.631.924.1135
Number of Employees: 324


Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.